Back to search

Michigan State University

Investigating outcomes of gene replacement therapy in the RPE65-deficient dog

Abstract

dc:description

Treatment of Leber Congenital Amaurosis (LCA) caused by RPE65 gene mutations with recombinant adeno-associated virus (rAAV) mediated subretinal gene replacement therapy has been shown to be safe and effective through phase I/II clinical trials. The purpose of the four studies that comprise this thesis were to further evaluate gene therapy outcomes using the RPE65-deficient canine model. To study the success of treatment in the presence of retinal degeneration treatment of older RPE65-deficient dogs (2-6 years of age) was performed, demonstrating improved retinal function, as assessed by electroretinography (ERG), and improved vision testing outcomes. The effect of immune responses on treatment the second eye after prior treatment of the first eye of RPE65-deficient dogs was also studied, finding evidence of safety and efficacy equal to that seen in the first treated eye. These findings supported inclusion of the second eye in current human clinical trials, and this has since commenced. For these and subsequent studies a description of the phenotype of older RPE65-deficient dogs, and changes with age were evaluated, this included description of a previously unreported region of photoreceptor loss at the area centralis. Additionally, these studies required evidence that improvements in vision testing outcomes of an objective canine vision testing apparatus were due to the given therapy alone, and this was provided.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Annear, Matthew
Contributors dc:contributor
  • Petersen-Jones, Simon
  • Fyfe, John
  • Weber, Art
  • Bartoe, Joshua

Subjects

dc:subject × 4

Rights

dc:rights
Statement dc:rights
  • In Copyright
Language dc:language
English

Identifiers

dc:identifier.*
Identifier
etd:725
isbn:9781267608185
isbn:1267608188
oclc:931869493
umi:1518564
local:Annear_grad.msu_0128N_11561

Chain of custody

source
Harvested from
Michigan State University
Base URL
d.lib.msu.edu/oai
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Annear, Matthew. Investigating outcomes of gene replacement therapy in the RPE65-deficient dog. 2012. https://doi.org/doi:10.25335/m21p-jt07